Clinical trial
Intra-arterial Lutetium-177-dotatate for Treatment of Patients With…
NCT03590119 · Marnix Lam, Other · Completed
Key facts
| NCT number | NCT03590119 |
|---|---|
| Title | Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver Metastases |
| Official title | Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver Metastases |
| Acronym | LUTIA |
| Lead sponsor | Marnix Lam, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Neuroendocrine Tumors, Liver Metastases |
| Intervention type | Drug |
| Interventions | Lutetium Lu 177-DOTATATE |
| Enrollment | 26 |
| Start date | Aug 1, 2018 |
| Primary completion | Sep 1, 2022 |
| Completion | Sep 1, 2022 |
| First posted | Jul 18, 2018 |
| Last update posted | Nov 8, 2022 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: